Global Cancer Gene Therapy Market Insights, Forecast to 2029
This report presents an overview of global market for Cancer Gene Therapy market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Cancer Gene Therapy, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Cancer Gene Therapy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Cancer Gene Therapy revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Cancer Gene Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Cancer Gene Therapy revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Adaptimmune, Bluebird bio, Celgene, Shanghai Sunway Biotech, Shenzhen SiBiono GeneTech, SynerGene Therapeutics, Altor BioScience, Amgen and Argenx, etc.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Cancer Gene Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Gene Therapy companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cancer Gene Therapy revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
This report researches the key producers of Cancer Gene Therapy, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Cancer Gene Therapy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Cancer Gene Therapy revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Cancer Gene Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Cancer Gene Therapy revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Adaptimmune, Bluebird bio, Celgene, Shanghai Sunway Biotech, Shenzhen SiBiono GeneTech, SynerGene Therapeutics, Altor BioScience, Amgen and Argenx, etc.
By Company
- Adaptimmune
- Bluebird bio
- Celgene
- Shanghai Sunway Biotech
- Shenzhen SiBiono GeneTech
- SynerGene Therapeutics
- Altor BioScience
- Amgen
- Argenx
- BioCancell
- GlaxoSmithKline
- Merck
- OncoGenex Pharmaceuticals
- Transgene
- Oncolytic Virotherapy
- Gene Transfer
- Gene-Induced Immunotherapy
- Hospitals
- Diagnostics Centers
- Research Institutes
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East, Africa, and Latin America
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Cancer Gene Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Gene Therapy companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cancer Gene Therapy revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 CERAMIC PLA FILAMENT MARKET OVERVIEW
1.1 Product Definition
1.2 Ceramic PLA Filament Segment by Type
1.2.1 Global Ceramic PLA Filament Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 1.75 mm Type
1.2.3 2.85 mm/3 mm Type
1.3 Ceramic PLA Filament Segment by Application
1.3.1 Global Ceramic PLA Filament Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Automotive
1.3.3 Medical
1.3.4 Education
1.3.5 Others
1.4 Global Market Growth Prospects
1.4.1 Global Ceramic PLA Filament Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Ceramic PLA Filament Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Ceramic PLA Filament Production Estimates and Forecasts (2018-2029)
1.4.4 Global Ceramic PLA Filament Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 MARKET COMPETITION BY MANUFACTURERS
2.1 Global Ceramic PLA Filament Production Market Share by Manufacturers (2018-2023)
2.2 Global Ceramic PLA Filament Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of Ceramic PLA Filament, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Ceramic PLA Filament Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Ceramic PLA Filament Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Ceramic PLA Filament, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Ceramic PLA Filament, Product Offered and Application
2.8 Global Key Manufacturers of Ceramic PLA Filament, Date of Enter into This Industry
2.9 Ceramic PLA Filament Market Competitive Situation and Trends
2.9.1 Ceramic PLA Filament Market Concentration Rate
2.9.2 Global 5 and 10 Largest Ceramic PLA Filament Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 CERAMIC PLA FILAMENT PRODUCTION BY REGION
3.1 Global Ceramic PLA Filament Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Ceramic PLA Filament Production Value by Region (2018-2029)
3.2.1 Global Ceramic PLA Filament Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Ceramic PLA Filament by Region (2024-2029)
3.3 Global Ceramic PLA Filament Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Ceramic PLA Filament Production by Region (2018-2029)
3.4.1 Global Ceramic PLA Filament Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Ceramic PLA Filament by Region (2024-2029)
3.5 Global Ceramic PLA Filament Market Price Analysis by Region (2018-2023)
3.6 Global Ceramic PLA Filament Production and Value, Year-over-Year Growth
3.6.1 North America Ceramic PLA Filament Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Ceramic PLA Filament Production Value Estimates and Forecasts (2018-2029)
3.6.3 China Ceramic PLA Filament Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan Ceramic PLA Filament Production Value Estimates and Forecasts (2018-2029)
4 CERAMIC PLA FILAMENT CONSUMPTION BY REGION
4.1 Global Ceramic PLA Filament Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Ceramic PLA Filament Consumption by Region (2018-2029)
4.2.1 Global Ceramic PLA Filament Consumption by Region (2018-2023)
4.2.2 Global Ceramic PLA Filament Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Ceramic PLA Filament Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Ceramic PLA Filament Consumption by Country (2018-2029)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Ceramic PLA Filament Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Ceramic PLA Filament Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Ceramic PLA Filament Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Ceramic PLA Filament Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Ceramic PLA Filament Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Ceramic PLA Filament Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 SEGMENT BY TYPE
5.1 Global Ceramic PLA Filament Production by Type (2018-2029)
5.1.1 Global Ceramic PLA Filament Production by Type (2018-2023)
5.1.2 Global Ceramic PLA Filament Production by Type (2024-2029)
5.1.3 Global Ceramic PLA Filament Production Market Share by Type (2018-2029)
5.2 Global Ceramic PLA Filament Production Value by Type (2018-2029)
5.2.1 Global Ceramic PLA Filament Production Value by Type (2018-2023)
5.2.2 Global Ceramic PLA Filament Production Value by Type (2024-2029)
5.2.3 Global Ceramic PLA Filament Production Value Market Share by Type (2018-2029)
5.3 Global Ceramic PLA Filament Price by Type (2018-2029)
6 SEGMENT BY APPLICATION
6.1 Global Ceramic PLA Filament Production by Application (2018-2029)
6.1.1 Global Ceramic PLA Filament Production by Application (2018-2023)
6.1.2 Global Ceramic PLA Filament Production by Application (2024-2029)
6.1.3 Global Ceramic PLA Filament Production Market Share by Application (2018-2029)
6.2 Global Ceramic PLA Filament Production Value by Application (2018-2029)
6.2.1 Global Ceramic PLA Filament Production Value by Application (2018-2023)
6.2.2 Global Ceramic PLA Filament Production Value by Application (2024-2029)
6.2.3 Global Ceramic PLA Filament Production Value Market Share by Application (2018-2029)
6.3 Global Ceramic PLA Filament Price by Application (2018-2029)
7 KEY COMPANIES PROFILED
7.1 WOL3D
7.1.1 WOL3D Ceramic PLA Filament Corporation Information
7.1.2 WOL3D Ceramic PLA Filament Product Portfolio
7.1.3 WOL3D Ceramic PLA Filament Production, Value, Price and Gross Margin (2018-2023)
7.1.4 WOL3D Main Business and Markets Served
7.1.5 WOL3D Recent Developments/Updates
7.2 3DCeram
7.2.1 3DCeram Ceramic PLA Filament Corporation Information
7.2.2 3DCeram Ceramic PLA Filament Product Portfolio
7.2.3 3DCeram Ceramic PLA Filament Production, Value, Price and Gross Margin (2018-2023)
7.2.4 3DCeram Main Business and Markets Served
7.2.5 3DCeram Recent Developments/Updates
7.3 3D-Fuel
7.3.1 3D-Fuel Ceramic PLA Filament Corporation Information
7.3.2 3D-Fuel Ceramic PLA Filament Product Portfolio
7.3.3 3D-Fuel Ceramic PLA Filament Production, Value, Price and Gross Margin (2018-2023)
7.3.4 3D-Fuel Main Business and Markets Served
7.3.5 3D-Fuel Recent Developments/Updates
7.4 EUMAKERS
7.4.1 EUMAKERS Ceramic PLA Filament Corporation Information
7.4.2 EUMAKERS Ceramic PLA Filament Product Portfolio
7.4.3 EUMAKERS Ceramic PLA Filament Production, Value, Price and Gross Margin (2018-2023)
7.4.4 EUMAKERS Main Business and Markets Served
7.4.5 EUMAKERS Recent Developments/Updates
7.5 Formlabs
7.5.1 Formlabs Ceramic PLA Filament Corporation Information
7.5.2 Formlabs Ceramic PLA Filament Product Portfolio
7.5.3 Formlabs Ceramic PLA Filament Production, Value, Price and Gross Margin (2018-2023)
7.5.4 Formlabs Main Business and Markets Served
7.5.5 Formlabs Recent Developments/Updates
7.6 FrontierFila
7.6.1 FrontierFila Ceramic PLA Filament Corporation Information
7.6.2 FrontierFila Ceramic PLA Filament Product Portfolio
7.6.3 FrontierFila Ceramic PLA Filament Production, Value, Price and Gross Margin (2018-2023)
7.6.4 FrontierFila Main Business and Markets Served
7.6.5 FrontierFila Recent Developments/Updates
7.7 Roboze
7.7.1 Roboze Ceramic PLA Filament Corporation Information
7.7.2 Roboze Ceramic PLA Filament Product Portfolio
7.7.3 Roboze Ceramic PLA Filament Production, Value, Price and Gross Margin (2018-2023)
7.7.4 Roboze Main Business and Markets Served
7.7.5 Roboze Recent Developments/Updates
7.8 SiCeram
7.8.1 SiCeram Ceramic PLA Filament Corporation Information
7.8.2 SiCeram Ceramic PLA Filament Product Portfolio
7.8.3 SiCeram Ceramic PLA Filament Production, Value, Price and Gross Margin (2018-2023)
7.8.4 SiCeram Main Business and Markets Served
7.7.5 SiCeram Recent Developments/Updates
7.9 Spectrum Filaments
7.9.1 Spectrum Filaments Ceramic PLA Filament Corporation Information
7.9.2 Spectrum Filaments Ceramic PLA Filament Product Portfolio
7.9.3 Spectrum Filaments Ceramic PLA Filament Production, Value, Price and Gross Margin (2018-2023)
7.9.4 Spectrum Filaments Main Business and Markets Served
7.9.5 Spectrum Filaments Recent Developments/Updates
7.10 Tethon 3D
7.10.1 Tethon 3D Ceramic PLA Filament Corporation Information
7.10.2 Tethon 3D Ceramic PLA Filament Product Portfolio
7.10.3 Tethon 3D Ceramic PLA Filament Production, Value, Price and Gross Margin (2018-2023)
7.10.4 Tethon 3D Main Business and Markets Served
7.10.5 Tethon 3D Recent Developments/Updates
7.11 The Virtual Foundry (TVF)
7.11.1 The Virtual Foundry (TVF) Ceramic PLA Filament Corporation Information
7.11.2 The Virtual Foundry (TVF) Ceramic PLA Filament Product Portfolio
7.11.3 The Virtual Foundry (TVF) Ceramic PLA Filament Production, Value, Price and Gross Margin (2018-2023)
7.11.4 The Virtual Foundry (TVF) Main Business and Markets Served
7.11.5 The Virtual Foundry (TVF) Recent Developments/Updates
7.12 Zyltech
7.12.1 Zyltech Ceramic PLA Filament Corporation Information
7.12.2 Zyltech Ceramic PLA Filament Product Portfolio
7.12.3 Zyltech Ceramic PLA Filament Production, Value, Price and Gross Margin (2018-2023)
7.12.4 Zyltech Main Business and Markets Served
7.12.5 Zyltech Recent Developments/Updates
8 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
8.1 Ceramic PLA Filament Industry Chain Analysis
8.2 Ceramic PLA Filament Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Ceramic PLA Filament Production Mode & Process
8.4 Ceramic PLA Filament Sales and Marketing
8.4.1 Ceramic PLA Filament Sales Channels
8.4.2 Ceramic PLA Filament Distributors
8.5 Ceramic PLA Filament Customers
9 CERAMIC PLA FILAMENT MARKET DYNAMICS
9.1 Ceramic PLA Filament Industry Trends
9.2 Ceramic PLA Filament Market Drivers
9.3 Ceramic PLA Filament Market Challenges
9.4 Ceramic PLA Filament Market Restraints
10 RESEARCH FINDING AND CONCLUSION
11 METHODOLOGY AND DATA SOURCE
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
1.1 Product Definition
1.2 Ceramic PLA Filament Segment by Type
1.2.1 Global Ceramic PLA Filament Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 1.75 mm Type
1.2.3 2.85 mm/3 mm Type
1.3 Ceramic PLA Filament Segment by Application
1.3.1 Global Ceramic PLA Filament Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Automotive
1.3.3 Medical
1.3.4 Education
1.3.5 Others
1.4 Global Market Growth Prospects
1.4.1 Global Ceramic PLA Filament Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Ceramic PLA Filament Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Ceramic PLA Filament Production Estimates and Forecasts (2018-2029)
1.4.4 Global Ceramic PLA Filament Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 MARKET COMPETITION BY MANUFACTURERS
2.1 Global Ceramic PLA Filament Production Market Share by Manufacturers (2018-2023)
2.2 Global Ceramic PLA Filament Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of Ceramic PLA Filament, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Ceramic PLA Filament Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Ceramic PLA Filament Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Ceramic PLA Filament, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Ceramic PLA Filament, Product Offered and Application
2.8 Global Key Manufacturers of Ceramic PLA Filament, Date of Enter into This Industry
2.9 Ceramic PLA Filament Market Competitive Situation and Trends
2.9.1 Ceramic PLA Filament Market Concentration Rate
2.9.2 Global 5 and 10 Largest Ceramic PLA Filament Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 CERAMIC PLA FILAMENT PRODUCTION BY REGION
3.1 Global Ceramic PLA Filament Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Ceramic PLA Filament Production Value by Region (2018-2029)
3.2.1 Global Ceramic PLA Filament Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Ceramic PLA Filament by Region (2024-2029)
3.3 Global Ceramic PLA Filament Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Ceramic PLA Filament Production by Region (2018-2029)
3.4.1 Global Ceramic PLA Filament Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Ceramic PLA Filament by Region (2024-2029)
3.5 Global Ceramic PLA Filament Market Price Analysis by Region (2018-2023)
3.6 Global Ceramic PLA Filament Production and Value, Year-over-Year Growth
3.6.1 North America Ceramic PLA Filament Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Ceramic PLA Filament Production Value Estimates and Forecasts (2018-2029)
3.6.3 China Ceramic PLA Filament Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan Ceramic PLA Filament Production Value Estimates and Forecasts (2018-2029)
4 CERAMIC PLA FILAMENT CONSUMPTION BY REGION
4.1 Global Ceramic PLA Filament Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Ceramic PLA Filament Consumption by Region (2018-2029)
4.2.1 Global Ceramic PLA Filament Consumption by Region (2018-2023)
4.2.2 Global Ceramic PLA Filament Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Ceramic PLA Filament Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Ceramic PLA Filament Consumption by Country (2018-2029)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Ceramic PLA Filament Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Ceramic PLA Filament Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Ceramic PLA Filament Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Ceramic PLA Filament Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Ceramic PLA Filament Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Ceramic PLA Filament Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 SEGMENT BY TYPE
5.1 Global Ceramic PLA Filament Production by Type (2018-2029)
5.1.1 Global Ceramic PLA Filament Production by Type (2018-2023)
5.1.2 Global Ceramic PLA Filament Production by Type (2024-2029)
5.1.3 Global Ceramic PLA Filament Production Market Share by Type (2018-2029)
5.2 Global Ceramic PLA Filament Production Value by Type (2018-2029)
5.2.1 Global Ceramic PLA Filament Production Value by Type (2018-2023)
5.2.2 Global Ceramic PLA Filament Production Value by Type (2024-2029)
5.2.3 Global Ceramic PLA Filament Production Value Market Share by Type (2018-2029)
5.3 Global Ceramic PLA Filament Price by Type (2018-2029)
6 SEGMENT BY APPLICATION
6.1 Global Ceramic PLA Filament Production by Application (2018-2029)
6.1.1 Global Ceramic PLA Filament Production by Application (2018-2023)
6.1.2 Global Ceramic PLA Filament Production by Application (2024-2029)
6.1.3 Global Ceramic PLA Filament Production Market Share by Application (2018-2029)
6.2 Global Ceramic PLA Filament Production Value by Application (2018-2029)
6.2.1 Global Ceramic PLA Filament Production Value by Application (2018-2023)
6.2.2 Global Ceramic PLA Filament Production Value by Application (2024-2029)
6.2.3 Global Ceramic PLA Filament Production Value Market Share by Application (2018-2029)
6.3 Global Ceramic PLA Filament Price by Application (2018-2029)
7 KEY COMPANIES PROFILED
7.1 WOL3D
7.1.1 WOL3D Ceramic PLA Filament Corporation Information
7.1.2 WOL3D Ceramic PLA Filament Product Portfolio
7.1.3 WOL3D Ceramic PLA Filament Production, Value, Price and Gross Margin (2018-2023)
7.1.4 WOL3D Main Business and Markets Served
7.1.5 WOL3D Recent Developments/Updates
7.2 3DCeram
7.2.1 3DCeram Ceramic PLA Filament Corporation Information
7.2.2 3DCeram Ceramic PLA Filament Product Portfolio
7.2.3 3DCeram Ceramic PLA Filament Production, Value, Price and Gross Margin (2018-2023)
7.2.4 3DCeram Main Business and Markets Served
7.2.5 3DCeram Recent Developments/Updates
7.3 3D-Fuel
7.3.1 3D-Fuel Ceramic PLA Filament Corporation Information
7.3.2 3D-Fuel Ceramic PLA Filament Product Portfolio
7.3.3 3D-Fuel Ceramic PLA Filament Production, Value, Price and Gross Margin (2018-2023)
7.3.4 3D-Fuel Main Business and Markets Served
7.3.5 3D-Fuel Recent Developments/Updates
7.4 EUMAKERS
7.4.1 EUMAKERS Ceramic PLA Filament Corporation Information
7.4.2 EUMAKERS Ceramic PLA Filament Product Portfolio
7.4.3 EUMAKERS Ceramic PLA Filament Production, Value, Price and Gross Margin (2018-2023)
7.4.4 EUMAKERS Main Business and Markets Served
7.4.5 EUMAKERS Recent Developments/Updates
7.5 Formlabs
7.5.1 Formlabs Ceramic PLA Filament Corporation Information
7.5.2 Formlabs Ceramic PLA Filament Product Portfolio
7.5.3 Formlabs Ceramic PLA Filament Production, Value, Price and Gross Margin (2018-2023)
7.5.4 Formlabs Main Business and Markets Served
7.5.5 Formlabs Recent Developments/Updates
7.6 FrontierFila
7.6.1 FrontierFila Ceramic PLA Filament Corporation Information
7.6.2 FrontierFila Ceramic PLA Filament Product Portfolio
7.6.3 FrontierFila Ceramic PLA Filament Production, Value, Price and Gross Margin (2018-2023)
7.6.4 FrontierFila Main Business and Markets Served
7.6.5 FrontierFila Recent Developments/Updates
7.7 Roboze
7.7.1 Roboze Ceramic PLA Filament Corporation Information
7.7.2 Roboze Ceramic PLA Filament Product Portfolio
7.7.3 Roboze Ceramic PLA Filament Production, Value, Price and Gross Margin (2018-2023)
7.7.4 Roboze Main Business and Markets Served
7.7.5 Roboze Recent Developments/Updates
7.8 SiCeram
7.8.1 SiCeram Ceramic PLA Filament Corporation Information
7.8.2 SiCeram Ceramic PLA Filament Product Portfolio
7.8.3 SiCeram Ceramic PLA Filament Production, Value, Price and Gross Margin (2018-2023)
7.8.4 SiCeram Main Business and Markets Served
7.7.5 SiCeram Recent Developments/Updates
7.9 Spectrum Filaments
7.9.1 Spectrum Filaments Ceramic PLA Filament Corporation Information
7.9.2 Spectrum Filaments Ceramic PLA Filament Product Portfolio
7.9.3 Spectrum Filaments Ceramic PLA Filament Production, Value, Price and Gross Margin (2018-2023)
7.9.4 Spectrum Filaments Main Business and Markets Served
7.9.5 Spectrum Filaments Recent Developments/Updates
7.10 Tethon 3D
7.10.1 Tethon 3D Ceramic PLA Filament Corporation Information
7.10.2 Tethon 3D Ceramic PLA Filament Product Portfolio
7.10.3 Tethon 3D Ceramic PLA Filament Production, Value, Price and Gross Margin (2018-2023)
7.10.4 Tethon 3D Main Business and Markets Served
7.10.5 Tethon 3D Recent Developments/Updates
7.11 The Virtual Foundry (TVF)
7.11.1 The Virtual Foundry (TVF) Ceramic PLA Filament Corporation Information
7.11.2 The Virtual Foundry (TVF) Ceramic PLA Filament Product Portfolio
7.11.3 The Virtual Foundry (TVF) Ceramic PLA Filament Production, Value, Price and Gross Margin (2018-2023)
7.11.4 The Virtual Foundry (TVF) Main Business and Markets Served
7.11.5 The Virtual Foundry (TVF) Recent Developments/Updates
7.12 Zyltech
7.12.1 Zyltech Ceramic PLA Filament Corporation Information
7.12.2 Zyltech Ceramic PLA Filament Product Portfolio
7.12.3 Zyltech Ceramic PLA Filament Production, Value, Price and Gross Margin (2018-2023)
7.12.4 Zyltech Main Business and Markets Served
7.12.5 Zyltech Recent Developments/Updates
8 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
8.1 Ceramic PLA Filament Industry Chain Analysis
8.2 Ceramic PLA Filament Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Ceramic PLA Filament Production Mode & Process
8.4 Ceramic PLA Filament Sales and Marketing
8.4.1 Ceramic PLA Filament Sales Channels
8.4.2 Ceramic PLA Filament Distributors
8.5 Ceramic PLA Filament Customers
9 CERAMIC PLA FILAMENT MARKET DYNAMICS
9.1 Ceramic PLA Filament Industry Trends
9.2 Ceramic PLA Filament Market Drivers
9.3 Ceramic PLA Filament Market Challenges
9.4 Ceramic PLA Filament Market Restraints
10 RESEARCH FINDING AND CONCLUSION
11 METHODOLOGY AND DATA SOURCE
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
LIST OF TABLES
Table 1. Global Cancer Gene Therapy Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Oncolytic Virotherapy
Table 3. Key Players of Gene Transfer
Table 4. Key Players of Gene-Induced Immunotherapy
Table 5. Global Cancer Gene Therapy Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 6. Global Cancer Gene Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Cancer Gene Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Cancer Gene Therapy Market Share by Region (2018-2023)
Table 9. Global Cancer Gene Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Cancer Gene Therapy Market Share by Region (2024-2029)
Table 11. Cancer Gene Therapy Market Trends
Table 12. Cancer Gene Therapy Market Drivers
Table 13. Cancer Gene Therapy Market Challenges
Table 14. Cancer Gene Therapy Market Restraints
Table 15. Global Cancer Gene Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Cancer Gene Therapy Revenue Share by Players (2018-2023)
Table 17. Global Top Cancer Gene Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Gene Therapy as of 2022)
Table 18. Global Cancer Gene Therapy Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by Cancer Gene Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of Cancer Gene Therapy, Headquarters and Area Served
Table 21. Global Key Players of Cancer Gene Therapy, Product and Application
Table 22. Global Key Players of Cancer Gene Therapy, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cancer Gene Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Cancer Gene Therapy Revenue Market Share by Type (2018-2023)
Table 26. Global Cancer Gene Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Cancer Gene Therapy Revenue Market Share by Type (2024-2029)
Table 28. Global Cancer Gene Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Cancer Gene Therapy Revenue Share by Application (2018-2023)
Table 30. Global Cancer Gene Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Cancer Gene Therapy Revenue Share by Application (2024-2029)
Table 32. North America Cancer Gene Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America Cancer Gene Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 34. North America Cancer Gene Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America Cancer Gene Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 36. North America Cancer Gene Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Cancer Gene Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Cancer Gene Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Cancer Gene Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe Cancer Gene Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 41. Europe Cancer Gene Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe Cancer Gene Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 43. Europe Cancer Gene Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Europe Cancer Gene Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe Cancer Gene Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 46. China Cancer Gene Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 47. China Cancer Gene Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 48. China Cancer Gene Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 49. China Cancer Gene Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 50. Asia Cancer Gene Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia Cancer Gene Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 52. Asia Cancer Gene Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia Cancer Gene Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Cancer Gene Therapy Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 55. Asia Cancer Gene Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia Cancer Gene Therapy Market Size by Region (2024-2029) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Cancer Gene Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Cancer Gene Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Cancer Gene Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Cancer Gene Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Cancer Gene Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 62. Middle East, Africa, and Latin America Cancer Gene Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Cancer Gene Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 64. Adaptimmune Company Details
Table 65. Adaptimmune Business Overview
Table 66. Adaptimmune Cancer Gene Therapy Product
Table 67. Adaptimmune Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 68. Adaptimmune Recent Developments
Table 69. Bluebird bio Company Details
Table 70. Bluebird bio Business Overview
Table 71. Bluebird bio Cancer Gene Therapy Product
Table 72. Bluebird bio Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 73. Bluebird bio Recent Developments
Table 74. Celgene Company Details
Table 75. Celgene Business Overview
Table 76. Celgene Cancer Gene Therapy Product
Table 77. Celgene Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 78. Celgene Recent Developments
Table 79. Shanghai Sunway Biotech Company Details
Table 80. Shanghai Sunway Biotech Business Overview
Table 81. Shanghai Sunway Biotech Cancer Gene Therapy Product
Table 82. Shanghai Sunway Biotech Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 83. Shanghai Sunway Biotech Recent Developments
Table 84. Shenzhen SiBiono GeneTech Company Details
Table 85. Shenzhen SiBiono GeneTech Business Overview
Table 86. Shenzhen SiBiono GeneTech Cancer Gene Therapy Product
Table 87. Shenzhen SiBiono GeneTech Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 88. Shenzhen SiBiono GeneTech Recent Developments
Table 89. SynerGene Therapeutics Company Details
Table 90. SynerGene Therapeutics Business Overview
Table 91. SynerGene Therapeutics Cancer Gene Therapy Product
Table 92. SynerGene Therapeutics Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 93. SynerGene Therapeutics Recent Developments
Table 94. Altor BioScience Company Details
Table 95. Altor BioScience Business Overview
Table 96. Altor BioScience Cancer Gene Therapy Product
Table 97. Altor BioScience Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 98. Altor BioScience Recent Developments
Table 99. Amgen Company Details
Table 100. Amgen Business Overview
Table 101. Amgen Cancer Gene Therapy Product
Table 102. Amgen Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 103. Amgen Recent Developments
Table 104. Argenx Company Details
Table 105. Argenx Business Overview
Table 106. Argenx Cancer Gene Therapy Product
Table 107. Argenx Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 108. Argenx Recent Developments
Table 109. BioCancell Company Details
Table 110. BioCancell Business Overview
Table 111. BioCancell Cancer Gene Therapy Product
Table 112. BioCancell Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 113. BioCancell Recent Developments
Table 114. GlaxoSmithKline Company Details
Table 115. GlaxoSmithKline Business Overview
Table 116. GlaxoSmithKline Cancer Gene Therapy Product
Table 117. GlaxoSmithKline Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 118. GlaxoSmithKline Recent Developments
Table 119. Merck Company Details
Table 120. Merck Business Overview
Table 121. Merck Cancer Gene Therapy Product
Table 122. Merck Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 123. Merck Recent Developments
Table 124. OncoGenex Pharmaceuticals Company Details
Table 125. OncoGenex Pharmaceuticals Business Overview
Table 126. OncoGenex Pharmaceuticals Cancer Gene Therapy Product
Table 127. OncoGenex Pharmaceuticals Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 128. OncoGenex Pharmaceuticals Recent Developments
Table 129. Transgene Company Details
Table 130. Transgene Business Overview
Table 131. Transgene Cancer Gene Therapy Product
Table 132. Transgene Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 133. Transgene Recent Developments
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
Table 1. Global Cancer Gene Therapy Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Oncolytic Virotherapy
Table 3. Key Players of Gene Transfer
Table 4. Key Players of Gene-Induced Immunotherapy
Table 5. Global Cancer Gene Therapy Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 6. Global Cancer Gene Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Cancer Gene Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Cancer Gene Therapy Market Share by Region (2018-2023)
Table 9. Global Cancer Gene Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Cancer Gene Therapy Market Share by Region (2024-2029)
Table 11. Cancer Gene Therapy Market Trends
Table 12. Cancer Gene Therapy Market Drivers
Table 13. Cancer Gene Therapy Market Challenges
Table 14. Cancer Gene Therapy Market Restraints
Table 15. Global Cancer Gene Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Cancer Gene Therapy Revenue Share by Players (2018-2023)
Table 17. Global Top Cancer Gene Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Gene Therapy as of 2022)
Table 18. Global Cancer Gene Therapy Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by Cancer Gene Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of Cancer Gene Therapy, Headquarters and Area Served
Table 21. Global Key Players of Cancer Gene Therapy, Product and Application
Table 22. Global Key Players of Cancer Gene Therapy, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cancer Gene Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Cancer Gene Therapy Revenue Market Share by Type (2018-2023)
Table 26. Global Cancer Gene Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Cancer Gene Therapy Revenue Market Share by Type (2024-2029)
Table 28. Global Cancer Gene Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Cancer Gene Therapy Revenue Share by Application (2018-2023)
Table 30. Global Cancer Gene Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Cancer Gene Therapy Revenue Share by Application (2024-2029)
Table 32. North America Cancer Gene Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America Cancer Gene Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 34. North America Cancer Gene Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America Cancer Gene Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 36. North America Cancer Gene Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Cancer Gene Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Cancer Gene Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Cancer Gene Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe Cancer Gene Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 41. Europe Cancer Gene Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe Cancer Gene Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 43. Europe Cancer Gene Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Europe Cancer Gene Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe Cancer Gene Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 46. China Cancer Gene Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 47. China Cancer Gene Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 48. China Cancer Gene Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 49. China Cancer Gene Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 50. Asia Cancer Gene Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia Cancer Gene Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 52. Asia Cancer Gene Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia Cancer Gene Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Cancer Gene Therapy Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 55. Asia Cancer Gene Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia Cancer Gene Therapy Market Size by Region (2024-2029) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Cancer Gene Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Cancer Gene Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Cancer Gene Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Cancer Gene Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Cancer Gene Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 62. Middle East, Africa, and Latin America Cancer Gene Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Cancer Gene Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 64. Adaptimmune Company Details
Table 65. Adaptimmune Business Overview
Table 66. Adaptimmune Cancer Gene Therapy Product
Table 67. Adaptimmune Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 68. Adaptimmune Recent Developments
Table 69. Bluebird bio Company Details
Table 70. Bluebird bio Business Overview
Table 71. Bluebird bio Cancer Gene Therapy Product
Table 72. Bluebird bio Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 73. Bluebird bio Recent Developments
Table 74. Celgene Company Details
Table 75. Celgene Business Overview
Table 76. Celgene Cancer Gene Therapy Product
Table 77. Celgene Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 78. Celgene Recent Developments
Table 79. Shanghai Sunway Biotech Company Details
Table 80. Shanghai Sunway Biotech Business Overview
Table 81. Shanghai Sunway Biotech Cancer Gene Therapy Product
Table 82. Shanghai Sunway Biotech Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 83. Shanghai Sunway Biotech Recent Developments
Table 84. Shenzhen SiBiono GeneTech Company Details
Table 85. Shenzhen SiBiono GeneTech Business Overview
Table 86. Shenzhen SiBiono GeneTech Cancer Gene Therapy Product
Table 87. Shenzhen SiBiono GeneTech Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 88. Shenzhen SiBiono GeneTech Recent Developments
Table 89. SynerGene Therapeutics Company Details
Table 90. SynerGene Therapeutics Business Overview
Table 91. SynerGene Therapeutics Cancer Gene Therapy Product
Table 92. SynerGene Therapeutics Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 93. SynerGene Therapeutics Recent Developments
Table 94. Altor BioScience Company Details
Table 95. Altor BioScience Business Overview
Table 96. Altor BioScience Cancer Gene Therapy Product
Table 97. Altor BioScience Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 98. Altor BioScience Recent Developments
Table 99. Amgen Company Details
Table 100. Amgen Business Overview
Table 101. Amgen Cancer Gene Therapy Product
Table 102. Amgen Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 103. Amgen Recent Developments
Table 104. Argenx Company Details
Table 105. Argenx Business Overview
Table 106. Argenx Cancer Gene Therapy Product
Table 107. Argenx Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 108. Argenx Recent Developments
Table 109. BioCancell Company Details
Table 110. BioCancell Business Overview
Table 111. BioCancell Cancer Gene Therapy Product
Table 112. BioCancell Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 113. BioCancell Recent Developments
Table 114. GlaxoSmithKline Company Details
Table 115. GlaxoSmithKline Business Overview
Table 116. GlaxoSmithKline Cancer Gene Therapy Product
Table 117. GlaxoSmithKline Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 118. GlaxoSmithKline Recent Developments
Table 119. Merck Company Details
Table 120. Merck Business Overview
Table 121. Merck Cancer Gene Therapy Product
Table 122. Merck Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 123. Merck Recent Developments
Table 124. OncoGenex Pharmaceuticals Company Details
Table 125. OncoGenex Pharmaceuticals Business Overview
Table 126. OncoGenex Pharmaceuticals Cancer Gene Therapy Product
Table 127. OncoGenex Pharmaceuticals Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 128. OncoGenex Pharmaceuticals Recent Developments
Table 129. Transgene Company Details
Table 130. Transgene Business Overview
Table 131. Transgene Cancer Gene Therapy Product
Table 132. Transgene Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 133. Transgene Recent Developments
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Cancer Gene Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Cancer Gene Therapy Market Share by Type: 2022 VS 2029
Figure 3. Oncolytic Virotherapy Features
Figure 4. Gene Transfer Features
Figure 5. Gene-Induced Immunotherapy Features
Figure 6. Global Cancer Gene Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Cancer Gene Therapy Market Share by Application: 2022 VS 2029
Figure 8. Hospitals Case Studies
Figure 9. Diagnostics Centers Case Studies
Figure 10. Research Institutes Case Studies
Figure 11. Cancer Gene Therapy Report Years Considered
Figure 12. Global Cancer Gene Therapy Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Cancer Gene Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Cancer Gene Therapy Market Share by Region: 2022 VS 2029
Figure 15. Global Cancer Gene Therapy Market Share by Players in 2022
Figure 16. Global Top Cancer Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Gene Therapy as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Cancer Gene Therapy Revenue in 2022
Figure 18. North America Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Cancer Gene Therapy Market Share by Type (2018-2029)
Figure 20. North America Cancer Gene Therapy Market Share by Application (2018-2029)
Figure 21. North America Cancer Gene Therapy Market Share by Country (2018-2029)
Figure 22. United States Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Cancer Gene Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 25. Europe Cancer Gene Therapy Market Share by Type (2018-2029)
Figure 26. Europe Cancer Gene Therapy Market Share by Application (2018-2029)
Figure 27. Europe Cancer Gene Therapy Market Share by Country (2018-2029)
Figure 28. Germany Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. China Cancer Gene Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 35. China Cancer Gene Therapy Market Share by Type (2018-2029)
Figure 36. China Cancer Gene Therapy Market Share by Application (2018-2029)
Figure 37. Asia Cancer Gene Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 38. Asia Cancer Gene Therapy Market Share by Type (2018-2029)
Figure 39. Asia Cancer Gene Therapy Market Share by Application (2018-2029)
Figure 40. Asia Cancer Gene Therapy Market Share by Region (2018-2029)
Figure 41. Japan Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. South Korea Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. China Taiwan Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. India Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Australia Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Cancer Gene Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Cancer Gene Therapy Market Share by Type (2018-2029)
Figure 49. Middle East, Africa, and Latin America Cancer Gene Therapy Market Share by Application (2018-2029)
Figure 50. Middle East, Africa, and Latin America Cancer Gene Therapy Market Share by Country (2018-2029)
Figure 51. Brazil Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Mexico Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Turkey Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Israel Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. GCC Countries Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Adaptimmune Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 58. Bluebird bio Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 59. Celgene Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 60. Shanghai Sunway Biotech Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 61. Shenzhen SiBiono GeneTech Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 62. SynerGene Therapeutics Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 63. Altor BioScience Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 64. Amgen Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 65. Argenx Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 66. BioCancell Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 67. GlaxoSmithKline Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 68. Merck Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 69. OncoGenex Pharmaceuticals Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 70. Transgene Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Figure 1. Global Cancer Gene Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Cancer Gene Therapy Market Share by Type: 2022 VS 2029
Figure 3. Oncolytic Virotherapy Features
Figure 4. Gene Transfer Features
Figure 5. Gene-Induced Immunotherapy Features
Figure 6. Global Cancer Gene Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Cancer Gene Therapy Market Share by Application: 2022 VS 2029
Figure 8. Hospitals Case Studies
Figure 9. Diagnostics Centers Case Studies
Figure 10. Research Institutes Case Studies
Figure 11. Cancer Gene Therapy Report Years Considered
Figure 12. Global Cancer Gene Therapy Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Cancer Gene Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Cancer Gene Therapy Market Share by Region: 2022 VS 2029
Figure 15. Global Cancer Gene Therapy Market Share by Players in 2022
Figure 16. Global Top Cancer Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Gene Therapy as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Cancer Gene Therapy Revenue in 2022
Figure 18. North America Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Cancer Gene Therapy Market Share by Type (2018-2029)
Figure 20. North America Cancer Gene Therapy Market Share by Application (2018-2029)
Figure 21. North America Cancer Gene Therapy Market Share by Country (2018-2029)
Figure 22. United States Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Cancer Gene Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 25. Europe Cancer Gene Therapy Market Share by Type (2018-2029)
Figure 26. Europe Cancer Gene Therapy Market Share by Application (2018-2029)
Figure 27. Europe Cancer Gene Therapy Market Share by Country (2018-2029)
Figure 28. Germany Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. China Cancer Gene Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 35. China Cancer Gene Therapy Market Share by Type (2018-2029)
Figure 36. China Cancer Gene Therapy Market Share by Application (2018-2029)
Figure 37. Asia Cancer Gene Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 38. Asia Cancer Gene Therapy Market Share by Type (2018-2029)
Figure 39. Asia Cancer Gene Therapy Market Share by Application (2018-2029)
Figure 40. Asia Cancer Gene Therapy Market Share by Region (2018-2029)
Figure 41. Japan Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. South Korea Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. China Taiwan Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. India Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Australia Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Cancer Gene Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Cancer Gene Therapy Market Share by Type (2018-2029)
Figure 49. Middle East, Africa, and Latin America Cancer Gene Therapy Market Share by Application (2018-2029)
Figure 50. Middle East, Africa, and Latin America Cancer Gene Therapy Market Share by Country (2018-2029)
Figure 51. Brazil Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Mexico Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Turkey Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Israel Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. GCC Countries Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Adaptimmune Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 58. Bluebird bio Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 59. Celgene Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 60. Shanghai Sunway Biotech Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 61. Shenzhen SiBiono GeneTech Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 62. SynerGene Therapeutics Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 63. Altor BioScience Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 64. Amgen Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 65. Argenx Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 66. BioCancell Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 67. GlaxoSmithKline Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 68. Merck Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 69. OncoGenex Pharmaceuticals Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 70. Transgene Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
